⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001868637

MARGOLIN YAEL

Reports to the SEC for 2 companies · JERUSALEM

Transactions

8

Companies

2

Filings

5

CIK

0001868637

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-12-27	POINT Biopharma Global Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−1,710 sh	—	—	0
2023-12-27	POINT Biopharma Global Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2023-12-27	POINT Biopharma Global Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25.6K sh	—	—	0
2023-12-27	POINT Biopharma Global Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−44.7K sh	—	—	0
2023-06-01	POINT Biopharma Global Inc.Stock Option (Right to Buy)A Award	Director	AAward	+44.7K sh	—	—	44,749
2022-11-21	POINT Biopharma Global Inc.P Purchase	Director	PPurchase	+1,710 sh	$6.56	+$11.2K	1,710
2022-06-02	POINT Biopharma Global Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25.6K sh	—	—	25,614
2021-07-06	POINT Biopharma Global Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

5

Accepted (ET)
Dec 274
MARGOLIN YAEL0001104659-23-129766
SEC(opens sec.gov)
Jun 54
MARGOLIN YAEL0001104659-23-068143
SEC(opens sec.gov)
Nov 234
MARGOLIN YAEL0001104659-22-121618
SEC(opens sec.gov)
Jun 64
MARGOLIN YAEL0001104659-22-068508
SEC(opens sec.gov)
Jul 84
MARGOLIN YAEL0001104659-21-090265
SEC(opens sec.gov)

Companies

2

Address

C/O SCINAI IMMUNOTHERAPEUTICS LTD. JERUSALEM BIOPARK, 2ND FLOOR

JERUSALEM, 9112002